Microgravity Manufacturing: India's Spacetech Startups Leading Drug Discovery
Explore how India's spacetech startups are pioneering microgravity manufacturing for drug discovery. Learn about key players like Serendipity, AnduraX, Akashalabdhi, and Ethereal.
LazyFounders

30 SEC SUMMARY
Discover how India's spacetech startups are leveraging microgravity for advanced drug discovery and pharmaceutical manufacturing. Key players like Serendipity, AnduraX, Akashalabdhi, and Ethereal are pioneering this new frontier, with support from global giants and Indian space agencies.
TABLE OF CONTENTS
KEY HIGHLIGHTS
- India's spacetech startups are exploring microgravity for drug discovery and manufacturing.
- Serendipity, AnduraX, Akashalabdhi, and Ethereal are leading the charge.
- Global players like Merck, Redwire, and Varda are commercializing microgravity manufacturing.
- India's space agency ISRO and IIT Madras are supporting these innovations.
INTRODUCTION
In 2026, microgravity manufacturing is emerging as a transformative frontier in drug discovery and pharmaceutical manufacturing. India's spacetech startups are at the forefront of this revolution, leveraging the unique conditions of microgravity to develop advanced drugs and materials.
MICROGRAVITY AND ITS BENEFITS
Microgravity, the near-weightless conditions of space, offers an environment that is difficult to replicate on Earth. Microgravity reduces the effects of convection, sedimentation, and buoyancy, allowing crystals to form with greater uniformity in size and structure. This property is crucial for pharmaceutical manufacturing, particularly for drug discovery and the development of advanced materials.
KEY INDIAN SPACETECH STARTUPS
Serendipity
Serendipity, an Odisha-based startup, made headlines by flight-testing a prototype satellite designed to carry out pharmaceutical manufacturing processes under microgravity conditions. The satellite, deployed about 400-500 km from Earth, remains in space for weeks or months and is equipped with an autonomous pharmaceutical factory called ‘Alchemy’.
AnduraX
Andhra Pradesh-based AnduraX is developing a reusable spaceplane that can remain in orbit for up to 90 days, supporting microgravity research and manufacturing. Founded in 2024 by Sree Supranayi and Nirvik Choudhury, the company targets global pharmaceutical firms exploring microgravity applications, particularly for protein crystallisation for drug discovery.
Akashalabdhi
Akashalabdhi, a Bengaluru-based aerospace engineering and manufacturing firm, is building inflatable modular space habitats. The company aims to act as the infrastructure layer for the low-Earth-orbit economy, enabling several critical manufacturing processes in space.
Ethereal
Ethereal Exploration Guild (the Guild), which raised $20.5 Mn in a Series A funding round led by TDK Ventures in January, is building a reusable medium-lift rocket around a novel reusable upper stage. The company is also working with pharmaceutical companies focused on in-space manufacturing.
GLOBAL PLAYERS IN MICROGRAVITY MANUFACTURING
The commercialisation of microgravity manufacturing is already underway globally. Merck has explored growing protein crystals in space to reformulate its cancer drug Keytruda, while Redwire formed SpaceMD to commercialise pharmaceutical products developed in space. Varda Space manufactures pharmaceutical products and grows unique drug crystals in microgravity before returning them to Earth.
INDIA'S ROLE IN THE GLOBAL MICROGRAVITY ECONOMY
India's spacetech ecosystem is beginning to explore this opportunity. The Indian Space Research Organisation (ISRO) is planning an independent modular space station, Bharatiya Antariksh Station, to conduct multidisciplinary microgravity experiments. ExTeM (ExtraTerrestrial Manufacturing) at IIT Madras is working on microgravity to develop advanced manufacturing technologies for space exploration and Earth.
FUTURE PROSPECTS
The pharmaceuticals-in-microgravity market is estimated at around $768 Mn in 2024 and is expected to grow to $3 Bn by 2033, representing a 16.7% CAGR. The broader in-space manufacturing market is forecast to grow from $1.5 Bn in 2026 to $3.5 Bn by 2030. Drug crystallisation and protein-folding improvements are the strongest near-term pharma use cases.
FAQs
**Q: What is microgravity manufacturing? **A: Microgravity manufacturing refers to the process of producing materials and pharmaceuticals in the near-weightless conditions of space, where gravity is largely absent.
**Q: How do Indian spacetech startups benefit from microgravity? **A: Indian spacetech startups benefit from microgravity by leveraging its unique conditions to develop advanced drugs and materials with properties difficult to achieve on Earth.
**Q: What role does ISRO play in India's spacetech ecosystem? **A: ISRO supports India's spacetech ecosystem by planning an independent modular space station and conducting multidisciplinary microgravity experiments.
CONCLUSION
India's spacetech startups are pioneering microgravity manufacturing for drug discovery and pharmaceutical manufacturing, with significant support from global players and Indian space agencies. As the market for microgravity manufacturing continues to grow, these startups are poised to play a pivotal role in shaping the global microgravity economy.
CALL-TO-ACTION
Stay ahead in India’s startup economy by exploring unlimited articles, trackers, and playbooks on blogy.in. Join 10,000+ founders, investors & operators to unlock special offers and stay updated with expert curation.
Sources
- inc42.com · 2026-08-26
India’s Spacetech Ecosystem Looks To Microgravity For Drug Discovery And Manufacturing India’s Spacetech Ecosystem Looks To Microgravity For Drug Discovery And Manufacturing
This story is an original summary and analysis written by LazyFounders from the reporting listed above. Facts are attributed to their original publishers; sections marked as analysis are LazyFounders's opinion. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links.


